JERSEY CITY, N.J--(BUSINESS WIRE)--Quantum Genomics Corp (QGC), a global biotechnology company seeking to develop treatments for metabolism diseases and cardiovascular pathologies, announces today that Jean-Pierre Riffaud has joined the company as head of preclinical development.
